PrivMed® X has been designed to produce personalised medicine for use by the active ingredient manufacturer. It opens complete new business models around patient centric medication, addressing e.g. gender differences in pharmacological response, paediatric healthcare, chronic diseases etc.
Features:
Unique gravimetric controlled high precision dosing (up to +/- 1mg) og API blends. Patented.
For each tablet in one batch an individual dosing can be set
Any tablet shape selectable
Multi-layer tablets capability
Highly intuitive HMI with easyOP functionality
GAMP 5 & FDA 21 CFR part 11 compliant
The important pressing parameters for each ingredient mixture can be determined and stored on a chip in the mixture container.
The readable chip on the transport containers (which can optionally be sealed) stores the compression parameters, and guarantee seamless transport documentation (tracking) to the distributors and pharmacies.
This prevents the use of counterfeit mixtures of active ingredients.
The entire individual tablet production process can thus easily be licensed and decentralised. This saves millions in investment for production and environmentally harmful blister packing. It also shifts the focus of the core business back to the development of new and better personalised medicine.
Developing tablets has never been easier:
Insert punch set and the container with your API blend.
Choose required parameter as tablet weight and analysis type, e.g. Heckel-Plot.
